Chu et al30 reported that SIRT1 was upregulated in drug‐resistant cancer cell lines and patients’ tumor samples through increasing expression level of multidrug resistant protein 1, which was reminiscent of SIRT1’s promoting effect in the sensitivity of chemotherapy drugs. The gene discussed is SIRT1; the disease is neoplasm.